Navigation Links
Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference

ontinuous release formulation of omega interferon with the Omega DUROS device may improve the treatment of HCV by offering a more convenient, potentially safer and more efficacious therapy for HCV patients."

About Omega DUROS Therapy

Omega DUROS therapy is being developed to improve the treatment of HCV by offering a more convenient and potentially safer and more effective treatment. Omega DUROS therapy is designed to deliver a continuous and consistent dose of omega interferon for three months via the implantable DUROS device, a drug delivery technology developed by ALZA Corporation, and licensed to Intarcia for use in certain broad fields. Another product incorporating the DUROS technology has already been approved by the FDA for the palliative treatment of prostate cancer. Intarcia is also leveraging the DUROS technology in evaluating other drug development opportunities. The most advanced of these is focused on the delivery of GLP-1 and GLP-1 analogs with the DUROS device for the treatment of type 2 diabetes.

About Intarcia

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapeutics for patients with chronic diseases in which there are significant unmet medical needs. Intarcia's drug development expertise and competitive edge are complemented by its ability to stabilize macromolecules and to deliver them in a constant and consistent manner via the proprietary DUROS drug delivery platform. The initial programs that Intarcia is pursuing are in hepatitis C and type 2 diabetes.

About Hepatitis C

Hepatitis C is a major global public health problem. According to the World Health Organization, more than 170 million people worldwide are chronically infected with HCV, and three to four million new HCV infections occur annually. The U.S. Centers for Disease Control and Prevention has estimated that in the United States approximately 3.2 million people are chronically infected with HCV and approximately 25,00
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:8/4/2015)... Aug. 4, 2015  Ironshore Pharmaceuticals & Development, ... Health, a company specializing in personalized medicine, to ... trial, designed to evaluate the safety and efficacy ... treat Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second ... Health originally partnered with Ironshore in 2014 and ...
(Date:8/3/2015)... 4, 2015   The Intellectual Property and ... leading provider of intelligent information for businesses and ... CMR Pharmaceutical R&D Factbook , the biopharmaceutical industry,s ... around declines in R&D, the analysis identifies a ... milestone and forecasts sales to reach $1.3 trillion ...
(Date:8/3/2015)... , Aug. 3, 2015  BC Technical, the nation,s ... Ohio Valley Medical Systems, one of the largest MRI ... addition of Ohio Valley Medical Systems allows BC Technical ... Hitachi MRI.   "We couldn,t be more ... President and CEO of BC Technical. "The Ohio Valley ...
Breaking Medicine Technology:Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Pharma Sales to Grow Beyond $1 Trillion 2BC Technical Acquires Ohio Valley Medical Systems 2
... Radioactive Microspheres in... -- ROME, August 19, 2010 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... Reportlinker.com announces that a new market research ... Advances in Large Scale BioManufacturing and Scale-Up ... A Comprehensive Study of ... This new ASM study provides a clear view ...
Cached Medicine Technology:Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 2Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 3Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 4Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 5Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 6Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 7Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 8Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy 9Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED 2Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED 3
(Date:8/4/2015)... ... 04, 2015 , ... More than 700 years of marital bliss were celebrated ... July 24th. Chaplains Shawn Kafader and Richard Oas lead the non-denominational service for ... was a reception, with music by the Moonlight Serenade Orchestra and a special honeymoon ...
(Date:8/4/2015)... ... August 04, 2015 , ... Loyola University New ... its RN to BSN and Master of Science in Nursing in Health ... 2020 from the Commission on Collegiate Nursing Education (CCNE), the nation’s ...
(Date:8/4/2015)... ... August 04, 2015 , ... Lightning Labels ... its Denver facility that will usher in a new standard of sticker and ... more effectively meet its twin objectives of quality and quantity without compromising ...
(Date:8/4/2015)... Ann Arbor, MI and Topeka, KS (PRWEB) , ... ... ... Health Information Network (KHIN) announced today their partnership to make the Isabel Symptom ... The Isabel Symptom Checker provides consumers a mechanism to check their symptoms in ...
(Date:8/3/2015)... ... August 04, 2015 , ... The American Academy ... The new internationally peer-reviewed Guidelines were prepared by members of the AAT as ... in evaluating patients with dental-oral and systemic health-related complaints. , Thermography is ...
Breaking Medicine News(10 mins):Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 2Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 3
... ... valuable information regarding the signs and symptoms of chiropractic stroke and the causes of ... ... has represented people severely injured by chiropractic neck manipulations, has launched a new website ...
... ... , ... (PRWEB) May 7, 2010 - Accumed Research Associates recently announced their continued growth by ... leading clinical trials facility in Garden City, NY, now offers opportunities for all phases ...
... ... Vice President Brian Albury will present a no-holds-barred look at Costa Rica and other countries ... America for purchasing real estate? , ... (PRWEB) May 7, 2010 -- While Costa Rica has long been the investment darling ...
... ... by the Southern Illinois University Edwardsville School of Pharmacy, today released its 40-page list ... release at the 29th Annual Scientific Meeting of the American Pain Society in Baltimore. ... Edwardsville, ...
... A Scientology ... says government and private sector cooperation against drug trafficking and drug abuse is essential and ... ... coalition of anti-drug activists Tuesday night at the new Church of Scientology of Los Angeles ...
... ... at Lipscomb University and McGavock High School over the weekend when the Cumberland River ... evacuate homes and hotels. , ... Nashville (Vocus) May 6, 2010 -- The Church of Scientology & Celebrity ...
Cached Medicine News:Health News:Chiropractic Stroke Website Launched To Aid Victims of Chiropractor Malpractice 2Health News:Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials 2Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 2Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 3Health News:SIUE Pain Summit Recommendations Announced Today 2Health News:SIUE Pain Summit Recommendations Announced Today 3Health News:Scientology Official Calls for Government-Community Cooperation to Attack Drug Abuse 2Health News:Church of Scientology Nashville Mobilizes Scientology Volunteer Ministers to Cope with Floods 2
... This therapeutic system is ... patient in mind. As ... and ongoing therapy, SONOCUR ... and effective therapy. Plus, ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... only one of the most modern lithotripters available ... from being designed for the treatment of the ... the MODULITH SLX can also be employed for ... equally suitable for the treatment of gallstones or ...
... The MINILITH SL1 developed by STORZ MEDICAL ... extensive experience in the field of kidney ... the specific requirements to be met by ... as has been outlined above. The MINILITH ...
Medicine Products: